Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice-Reference-Cited by-同舟云学术

Patient‐reported and clinician‐reported chemotherapy‐induced peripheral neuropathy in patients with early breast cancer: Current clinical practice

Published:2019-05-15 Issue:17 Volume:125 Page:2945-2954
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Nyrop Kirsten A.¹²^ORCID,Deal Allison M.²,Reeder‐Hayes Kathryn E.¹²^ORCID,Shachar Shlomit S.³,Reeve Bryce B.⁴^ORCID,Basch Ethan¹²,Choi Seul Ki⁵,Lee Jordan T.⁶,Wood William A.¹²,Anders Carey K.⁷,Carey Lisa A.¹²,Dees Elizabeth C.¹²,Jolly Trevor A.¹²,Kimmick Gretchen G.⁷,Karuturi Meghan S.⁸,Reinbolt Raquel E.⁹^ORCID,Speca JoEllen C.¹,Muss Hyman B.¹²

Affiliation:

1. Department of Medicine, School of Medicine University of North Carolina Chapel Hill North Carolina

2. Lineberger Comprehensive Cancer Center University of North Carolina at Chapel Hill Chapel Hill North Carolina

3. Rambam Health Campus Haifa Israel

4. Department of Population Health Sciences Duke University School of Medicine Durham North Carolina

5. Department of Health Behavior, Gillings School of Global Public Health University of North Carolina Chapel Hill North Carolina

6. Department of Exercise and Sport Science University of North Carolina Chapel Hill North Carolina

7. Department of Medicine Duke University School of Medicine Durham North Carolina

8. Department of Breast Medical OncologyMD Anderson Cancer Center, University of Texas Houston Texas

9. Department of Internal Medicine Ohio State University Comprehensive Cancer Center Columbus Ohio

Funder

Breast Cancer Research Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32175

Reference53 articles.

1. National Cancer Institute.Common Terminology Criteria for Adverse Events (CTCAE).https://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf. Accessed October 23 2017.

2. Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

3. Neuropathy Is Not Associated With Clinical Outcomes in Patients Receiving Adjuvant Taxane-Containing Therapy for Operable Breast Cancer

4. Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30

5. Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of exercise and doxorubicin on acute diaphragm neuromuscular transmission failure;Experimental Neurology;2024-08

2. Quality of Life Outcomes in Breast Cancer Patients Receiving Chemotherapy With or Without Radiation Therapy;Clinical Breast Cancer;2024-08

3. Identifying pre-habilitation targets for the mitigation of long-term side effects of chemotherapy in patients with early breast cancer;Supportive Care in Cancer;2024-07-19

4. Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Narrative Review and Proposed Theoretical Model;Cancers;2024-07-18

5. Quantitative analysis of the effect of docetaxel-induced edema on quality of life in patients with breast cancer and related factors: a prospective cohort study;BMC Women's Health;2024-03-07